Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 14 pseudogene 8 (SEPTIN14P8) is a genomic DNA sequence that resembles the SEPTIN14 gene but is classified as a pseudogene, which means it has accumulated genetic changes that render it nonfunctional—it does not encode a functional protein product[1][3][6]. Pseudogenes typically arise by gene duplication or retrotransposition and often lack promoters, introns, or functional coding capacity[1][3][6]. There is no evidence that SEPTIN14P8 contributes to human protein function, disease, or serves as a drug target. The predominant significance of pseudogenes like SEPTIN14P8 is in genomics and evolutionary studies, rather than as therapeutic targets or molecular biomarkers[1][5][6]. If you are seeking disease-relevant, druggable targets, pseudogenes such as SEPTIN14P8 are generally excluded from such lists because they do not produce functional proteins or participate directly in biological pathways[1][6]. If you require details about the functional SEPTIN14 gene or septin family proteins, those would constitute distinct queries.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 14 pseudogene 8 (SEPTIN14P8).